Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

Merck’s CEO Kenneth Frazier to retire after ten years in the role

Merck’s CEO Kenneth Frazier to retire after ten years in the role Under his leadership, Merck has seen impressive growth for its immunotherapy blockbuster Keytruda (pembrolizumab) and other innovative treatments.

BMS gains FDA approval for second Opdivo combo in kidney cancer

BMS gains FDA approval for second Opdivo combo in kidney cancer Armed with two Opdivo combinations in its arsenal, BMS is primed to take on Merck &Co/MSD’s blockbuster checkpoint inhibitor Keytruda (pembrolizumab) plus Pfizer’s TKI Inlyta (ipilimumab). ... Keytruda/Inlyta won an FDA approval in advanced RCC in

BMS aims for US approval of Opdivo combo in stomach cancer

BMS aims for US approval of Opdivo combo in stomach cancer If Opdivo wins an approval for first-line gastric cancer, it could gain an advantage over Merck &Co’s (MSD) rival checkpoint inhibitor Keytruda (pembrolizumab). ... In the Keynote-062 trial, Keytruda plus chemotherapy was not found to be statistically

New dosing option for AZ’s Imfinzi approved in the EU and UK

New dosing option for AZ’s Imfinzi approved in the EU and UK Merck &Co’s checkpoint inhibitor Keytruda (pembrolizumab) currently holds much of the NSCLC market, although the drug failed to show benefit in ES-SCLC when added to chemotherapy.

GSK pays $85m upfront for Surface Oncology’s lead cancer drug

GSK pays $85m upfront for Surface Oncology’s lead cancer drug The company is also collaborating with Merck &Co (MSD) on a clinical trial evaluating the safety and efficacy of SRF617 in combination with Merck’s blockbuster PD-1 inhibitor Keytruda (pembrolizumab).

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...